Covid-19 News

Quote from Fm1

Egypt’s existing national COVID-19 protocol includes Hydroxychloroquine, Budesonide, and several other treatments depending on the stage of infection

Interesting to see Egypt is still using HCQ. They started using it way back in March 2020. Hmmm....

Quote from Wyttenbach

The famous UK vaccination report: https://assets.publishing.serv…e_report_-_week_37_v2.pdf

Go to page 13!? Table 2. It looks like the vaccinated in the segment above age > 40 had 30% more CoV-19 cases than unvaccinated. Only age 80+ is 1:1 again...

Strange....

Not strange if you read my post which explains it - courtesy of the excellent radio 4 program More or Less about numbers, statistics etc which investigated it. That pots was only 12 hours ago. Strangely short memories...

Post

RE: Covid-19 News

That PHE (Public Health England) data on vaccinations

PHE published data on the ratio of people vaccinated and unvaccinated who are infected. According to their figures a higher proportion of vaccinated people make covid cases than uvaccinated.

That is a bit strange, though you could imagine possible reasons.

It is also false. There was a More-or-less radio program investigating this.

https://www.bbc.co.uk/programmes/p09vyy6h

Basically, to get the ratio of cases/vaccinated is easy. We know both…

THHuxleynew

Sep 19th 2021

Quote from Shane D.

While you disagree with the Pathologists theory for the increase he is seeing in cancers, you later on agree that he may very well be seeing such an increase:

I disagree with his anti-vax attribution of amy increase, and while there will be an increase - perhaps - the US has not had such a sustained lockdown as the UK and it is no way 20X

Quote from Shane D.

Sounds like an honest difference of opinion about causation between two experts IMO. I agree your theory sounds much more plausible than his. In fact, in the early days of the lockdowns, many doctors were warning the same thing; that patients were avoiding hospitals, and to expect an increase in cancers, heart attacks, etc as a result.

His theory that the vaccine is killing off the protective T-cells could have been influenced by his politics. In this pandemic, we have learned to "trust but verify"...everyone. No exceptions.

It is not a theory.

Shane, I realise you are not a scientist, but you fall always into the "false balance" fallacy where juts because two people can be found to say opposite things, even though what one said is ludicrous and counterfactual, you equate them.

You can do the same even-handed thing with Flat Earthers (yes they exist, and are very devoted to their theory). I am happy for nonsense to be posted. As Jed says we should know what these crackpots are saying. i am not happy for this site and thread to view it as valid scientific comment when it is neitehr (internally) valid nor scientific.

And calling vaccination needle rape is not a scientific comment at all, it is an emotional reaction.

mRNA COVID-19 Vaccination and Development of CMR-confirmed Myopericarditis

ABSTRACT

Introduction Several case reports or small series have suggested a possible link between mRNA COVID vaccines and the subsequent development of myocarditis and pericarditis. This study is a prospective collection and review of all cases with a myocarditis/pericarditis diagnosis over a 2-month period at an academic medical center.

Methods Prospective case series from 1st June 2021 until 31st July 2021. Patients were identified by admission and discharge diagnoses which included myocarditis or pericarditis. Inclusion criteria: in receipt of mRNA vaccine within one month prior to presentation; The CMR protocol included cine imaging, native T1 and T2 mapping, late gadolinium enhancement and post contrast T1 mapping. All CMR studies were read in consensus by two experienced readers. Diagnosis was based on clinical presentation, ECG/echo findings and serial troponins and was confirmed in each case by CMR. Incidence was estimated from total doses of mRNA vaccine administered in the Ottawa region for the matching time-period. This data was obtained from the Public Health Agency of Ottawa.

Results 32 patients were identified over the period of interest. Eighteen patients were diagnosed with myocarditis; 12 with myopericarditis; and 2 with pericarditis alone. The median age was 33 years (18-65 years). The sex ratio was 2 females to 29 males. In 5 cases, symptoms developed after only a single dose of mRNA vaccine. In 27 patients, symptoms developed after their second dose of. Median time between vaccine dose and symptoms was 1.5 days (1-26 days). Chest pain was the commonest symptom, but many others were reported. Non-syncopal non-sustained ventricular tachycardia was seen in only a single case. Median LV ejection fraction (EF) was 57% (44-66%). Nine patients had an LVEF below the normal threshold of 55%. Incidence of myopericarditis overall was approximately 10 cases for every 10,000 inoculations.

Summary and Conclusions This is the largest series in the literature to clearly relate the temporal relationship between mRNA COVID vaccination, symptoms and CMR findings. In most patients, symptom onset began within the first few days after vaccination with corresponding abnormalities in biomarkers and on ECG. Cardiac MRI confirmed acute myocardial and pericardial changes with the presence of edema demonstrated with both tissue mapping and late gadolinium enhancement. Symptoms settled quickly with standard therapy and patients were discharged within a few days. No major adverse cardiac events and no significant arrythmias were noted during inpatient stay. Further follow up will be required to ascertain the longer-term outcomes of this patient group.

Ivermectin, two other drugs being tested in MUSC COVID-19 clinical trial

Ivermectin, two other drugs being tested in MUSC COVID-19 clinical trial

Ivermectin, a drug used to treat parasitic infections, has been getting a lot of attention recently about whether it should be used to treat COVID-19.

www.waff.com

CHARLESTON, S.C. (WCSC) - Ivermectin, a drug used to treat parasitic infections, has been getting a lot of attention recently about whether it should be used to treat COVID-19. Now that drug and two others are being tested as part of a COVID-19 clinical trial that MUSC is participating in.

According to MUSC, there are limited options for COVID-19 treatments that are FDA approved and that are for patients who are not sick enough to be in the hospital. Doctors with MUSC said they hope this trial will help answer some questions about various treatments and dispel any incorrect information that has been swirling.

“We have seen a lot of misinformation out there, and unfortunately, some patients have received non-FDA approved medications outside of a clinical trial,” Rami Zebian, M.D. said in a release. “That is not a safe practice, and we have seen many reports of toxicity – and we have many unanswered questions.”

In addition to Ivermectin, fluticasone—a corticosteroid used for asthma or other conditions—and fluvoxamine—an antidepressant—are also included in the study.

Officials with MUSC said this is a safe way to see if these drugs are actually effective in reducing symptoms of the virus.

According to MUSC, this study is completely remote, so you do not need to live near an MUSC campus to participate. You also can pick which drug you would like to be assigned and you will either be given a placebo or the drug.

MUSC officials said if you are accepted into the trial, you will take the drug as directed, fill out daily surveys and respond to call questionnaires. After 90 days, each participant will receive a $100 Amazon gift card.

In order to be eligible to participate in the study, you have to be at least 30 years old, have a positive covid test in the last 10 days and be experiencing at least two COVID symptoms.

https://web.musc.edu/about/news-center/2021/09/17/trial-of-outpatient-drugs-for-covid19-opens-to-all-south-carolinians

Coronavirus mutated 30 times in South African woman: report

Coronavirus mutated 30 times in South African woman: report

The woman was HIV-positive and carried coronavirus for 216 days, bioinformatics professor Tulio de Oliveira says

www.geo.tv

The woman was HIV-positive.

She carried virus for 216 days.

Serval variants have originated in S Africa.

The coronavirus mutated at least 30 times as an HIV-positive South African woman carried the virus for 216 days, Bloomberg reported Monday.

The publication said Tulio de Oliveira, bioinformatics professor who runs gene-sequencing institutions at two South African universities, revealed the development at a conference.

“There is good evidence that prolonged infection in immunocompromised individuals is one mechanism for the emergence of COVID-19 variants", the bioinformatics professor said.

Africa, according to the publication, is the continent with the lowest vaccination numbers, and thus, several COVID-19 variants have originated here — beta mutation found in South Africa, eta from Nigeria, and most recently C.1.2, again from South Africa.

Meanwhile, President of the South African Medical Research Council Glenda Gray said people who are immunocompromised shed for much longer, and viral evolution happens when you are shedding.

“Speed and coverage are important to make sure that people who are HIV-positive are getting vaccinated," Gray added.

Quote from Fm1

Further follow up will be required to ascertain the longer-term outcomes of this patient group.

That's it!

Quote from Fm1

The coronavirus mutated at least 30 times as an HIV-positive South African woman carried the virus for 216 days, Bloomberg reported Monday.

That's why Ivermectin should be used! Stop the replication!!

Freemason's and Rotary big pharma mafia are willful killers!

Quote from THHuxleynew

Not strange if you read my post which explains it - courtesy of the excellent radio 4 program More or Less about numbers, statistics etc which investigated it.

You are silly! Read the official report (linked above) then you will learn how many vaccine dose have been spent.

Please also sort out your adult/ versus population problem and reduce the vaccinated group by 50% (at least! But delta has a higher dark factor - 6-8 - so 60% is most likely the today's factor) to get the real vaccine protected risk versus unvaccinated.

Quote from Wyttenbach

You are silly! Read the official report (linked above) then you will learn how many vaccine dose have been spent.

Please also sort out your adult/ versus population problem and reduce the vaccinated group by 50% (at least! But delta has a higher dark factor - 6-8 - so 60% is most likely the today's factor) to get the real vaccine protected risk versus unvaccinated.

You yourself said that result was strange.

You have either nor read, or are deliberately avoiding commenting on, the interesting reason why it is strange. Read my post which links all the details. (I even linked it again in my followup after you ignored it the first time).

Bottom line: UK figures show the real-world effects of the vaccine as 50% less infection than for unvaccinated.

Quote from THHuxleynew

Bottom line: UK figures show the real-world effects of the vaccine as 50% less infection than for unvaccinated.

Your knowledge is outdated. See table: Table 2. COVID-19 cases by vaccination status between week 33 and week 36 2021.

Age class 40-80 more CoV-19 cases among vaccinated...And this is the only class of concern! If you add the 50..60% infection protected, then this signal is very alarming as it shows that now this group (the subgroup that had no infection so far) gets 3x more often CoV-19 than unvaccinated. This is the true sign of immune suppression!

This is from real PCR+ cases. Does not include the hidden ones. Has also nothing to do with missing vaccinated/unvaccinted!

Tidewater Physicians Multispecialty Group Takes on the Molnupiravir ‘Household Contacts’ Phase 3 Clinical Trial

Tidewater Physicians Multispecialty Group Takes on the Molnupiravir ‘Household Contacts’ Phase 3 Clinical Trial

Based in Newport News, Virginia, Tidewater Physicians Multispecialty Group (TPMG) was formed in 1992 first as a primary care medical group. Today the

trialsitenews.com

Based in Newport News, Virginia, Tidewater Physicians Multispecialty Group (TPMG) was formed in 1992 first as a primary care medical group. Today the group includes 200 primary care, specialty physicians, and advanced practice clinicians in dozens of office locations across coastal Virginia. This multispecialty practice also serves as a trial site for research. Recently local press promoted a study at the TPMG Hampton Roads clinic emphasizing the introduction of an investigational antiviral that “may prevent unvaccinated people from getting COVID-19.” A strong claim, TrialSite investigated this trial site and the study drug.

It turns out that TPMG was recruited by Merck as part of the molnupiravir “MOVe-AHEAD study (NCT04939428) investigating the orally-administered, antiviral medication for COVID-19. Identified as site number 3495, TPMG’s participation is led by principal investigator Dr. Vijay Subramaniam. The recent local media entry explains the study drug as designed to “make genetic copying mistakes to prevent it from reproducing.”

What is the MOVEe-AHEAD study

Sponsored by Merck, this multicenter, randomized, double-blind, placebo-controlled study investigates the efficacy, as well as safety and tolerability of molnupiravir (MK-4482) in adults who reside with a person infected with COVID-19.

How many total Participants targeted?

1,332 total and 10 participants at the TPMG trial site location.

What is the study hypothesis?

Molnupiravir is superior to placebo in preventing laboratory-confirmed COVID-19 infection through Day 14 of the study in participants who do not have confirmed or suspected COVID-19 at time of screening and randomization.

Put another way this is a household “contacts” study meaning that individuals that reside with a household member that is infected with SARS-CoV-2 is a potential candidate for the study.

What is study duration?

August 2021 to April 3, 2022

What are the primary outcome measures or “endpoints”?

First, the sponsor seeks to measure the percentage of the participants on study drugs that actually were infected with SARS-CoV-2—meaning they test positive with the coronavirus in the first 14 days of the study. So, if study subjects start noticing symptoms such as cough or sore throat, they will have a nasopharyngeal (NP) swab test for SARS-CoV-2 using reverse-transcription polymerase chain reaction (RT-PCR).

Second, although a Phase 3 study, Merck is probing in this study for adverse events. The study team will monitor for adverse events up to 29 days from the start of the study. Finally, the study sponsor seeks to measure participants dropout due to adverse events within the first five days.

What are the inclusion criteria (Who can participate?)

First, the study participant must be 18 years of age and up and reside in a household with an individual with a documented COVID-19 infection, including 1) first positive SARS-CoV-2 test result from a sample collected within ≤5 days prior to randomization of the participant and 2) at least one symptom attributable to COVID-19. Second, the participant cannot have a SARS-CoV-2 infection themselves—again, this study was designed to determine if the Merck drug molnupiravir can prevent infection much like a prophylaxis 3) the participant must be willing to take an investigational oral medication 4) must be male and willing to be abstinent from heterosexual intercourse or use acceptable contraception during the study for ≥ 4 days post the last dose of study intervention and 5) if female—must not be pregnant/breastfeeding and at least one of the following applies during the study and for ≥ 4 days thereafter: A) is not a woman of childbearing potential B) is a woman of childbearing potential and uses highly effective contraception (low user dependency method or a user-dependent hormonal method in combination with a barrier method of C) a woman of childbearing age who is abstinent from heterosexual intercourse.

What are the exclusion criteria (Who cannot participate?)

This is a substantial list and includes a number of exclusions, including, of course, no prior history of laboratory-confirmed SARS-CoV-2 infection to a range of co-morbidities and other viruses to on existing therapies considered prohibited to any COVID-19 vaccination with the first dose ≥7 days prior to study randomization to a limit of 10 or more people in the household to a number of other exclusions.

How does the study work?

One-half of the study group receives the study drug, while the other half receives a placebo (looks like a study drug). Neither the patients nor the study team will know who has received the study drug or the placebo (masking).

What is the background of the PI at TPMG?

Vijay Subramaniam, MD, FCCP, is a board-certified Critical Care Medicine (2008), Pulmonary Medicine (2007), Internal Medicine (2004) and sleep Medicine (2016) and member of the American College of Chest Physician (Fellow), American Thoracic Society, Society of Critical Care Medicine, American Academy of Sleep Medicine, American Association of Cardiovascular and Pulmonary Rehabilitation, American Association of Chest Physician of Indian Origin and Association of Physician of India.

Dr. Subramaniam grew up in Logan, WV, and attended medical school at Mahadevappa Medical College, then joined Overlook Hospital in Summit, NJ, where he completed his internship in internal medicine. His residency was completed at Mercy Hospital of Pittsburgh; thereafter, he spent three years as a pulmonary and critical care fellow at Allegheny General Hospital.

What’s the PI’s POV of this Study

Dr. Subramaniam deems the investigational product’s prospects a “secondary prevention” measure declaring, of course, vaccination should be first. In an interview with the Pilot Online, the investigator stated, “The real goal is to give you a medicine that helps fight the virus off before it can get a hold of your body.”

Will Participants be Paid?

Yes. For travel, etc.

How many Trial Sites are involved?

According to the trial disclosed in the clinical trial registry, 43 trial sites are involved in 19 states across America as well as in the District of Columbia. The study also includes sites in France, Hungary, Spain, and Turkey.

Are there any safety data points in clinical trials?

In March 2021, Ridgeback Biotherapeutics and Merck reported preliminary results from a Phase 2a study evidencing positive data associated with secondary endpoint and no material safety issues. Four adverse events were deemed not associated with the study drug.

Has TPMG participated in other COVID-19 clinical trials?

Yes. Last year they served as a trial site for a study investigating a corticosteroid inhaler commonly used in asthma cases. The medical practice was able to recruit 70 participants with mild-to-moderate COVID-19 for that study. Note 60% of those participants were not patients of the practice.

Call to Action: Those that reside in or near South Hampton Roads or, more broadly, Northern Virginia can contact the group at [email protected]

https://www.businesswire.com/news/home/20210305005610/en/

"Tidewater Physicians Multispecialty Group Takes on the Molnupiravir ‘Household Contacts’ Phase 3 Clinical Trial"

......... Yes but does it kill worms in horses?.... for virtually nothing

Quote from jox

"Tidewater Physicians Multispecialty Group Takes on the Molnupiravir ‘Household Contacts’ Phase 3 Clinical Trial"

......... Yes but does it kill worms in horses?.... for virtually nothing

It does in dogs don't know about horses and no it costs a boatload ! But I'm already paying for it, the us government already bought 1.7 million does in June . Your tax dollars at work!

U.S. signs $1.2 bln deal for 1.7 mln courses of Merck's experimental COVID-19 drug

U.S. signs $1.2 bln deal for 1.7 mln courses of Merck's experimental COVID-19 drug

Merck & Co Inc (MRK.N) said on Wednesday the U.S. government has agreed to pay about $1.2 billion for 1.7 million courses of its experimental COVID-19…

www.reuters.com

Quote from Shane D.

While you disagree with the Pathologists theory for the increase he is seeing in cancers, you later on agree that he may very well be seeing such an increase:

I do not think a significant increase has been measured yet. I read that an increase is expected because in the last several months hospitals have been overwhelmed and treatment for cancer has been delayed. If this has happened, it will show up in statistics published next year. It takes a long time for public health stats to be published. COVID data is coming out almost instantly, but ordinary data for things like cancer and influenza runs about 6 months to a year behind. The CDC just recently published 2020-2021 flu season (meaning winter) data:

Upcoming 2020-2021 Influenza Season

What you need to know about the upcoming 2020-2021 influenza season in the United States.

www.cdc.gov

The pathologist is saying he sees an effect now. THH describes an effect that will take a while to occur (if it is significant), and will not appear in the stats until long after. Those are two very different hypotheses.

Here is a depressing article with social science stats describing people who refuse to be vaccinated.

Unvaccinated America, In 5 Charts

The COVID-19 pandemic is now, more than ever, a story about the unvaccinated. They’re the most vulnerable — in states reporting breakthrough infections, over…

fivethirtyeight.com

This chart is particularly depressing. This shows the harm caused by the antivaxxer Death Cult.

Is Biden Contradicting Federal Vaccine Policies On The International Stage? Yes.

Is Biden Contradicting Federal Vaccine Policies On The International Stage? Yes.

US President Joe Biden is set to deliver a call to arms at a virtual summit on the current state of the COVID-19 pandemic to members of the international

trialsitenews.com

US President Joe Biden is set to deliver a call to arms at a virtual summit on the current state of the COVID-19 pandemic to members of the international community, asking them to boost their efforts in delivering on their commitments to close the global vaccine inequity gap. According to multiple sources, President Biden wants to persuade other countries that produce vaccines internally to balance out their domestic needs for vaccination with the crisis of vaccine inequity across the developing world.

Set for Wednesday, Biden’s plea will be delivered during the annual meeting of the United Nations General Assembly in New York City. The primary governing body of the United Nations is expected to further discuss the global response to the pandemic and the worsening state of the global climate. To say the least, Biden’s strategy is exceptionally topical for the coming weeks of vaccine geopolitics. However, POTUS is positioning himself for further criticism for the apparent hypocrisy of the federal government’s Frankenstein monster of a vaccine policy. TrialSite had reported previously that Biden’s goal to implement booster vaccinations in America, tied with the controversial rollout of the national vaccine mandate expected to impact over 100 million Americans, is quickly evolving into a snowball of irony and contradiction expected to crash down on the country and the entire global community.

Please consider a few things. We don’t like being repetitive, but simple math shows a plethora of scenarios of what could go wrong if Biden and his administration don’t tighten up their approach to COVID-19 vaccines. First, the president and his public health team are expected to rebuke a recommendation given by the Food and Drug Administration advisory committee for vaccine approval that disapproved of Pfizer’s proposal to implement mass inoculations of their booster shot to a general population. Rather, the advisory committee overwhelmingly adopted a plan that targets booster doses for the elderly and other high-risk groups of immunocompromised individuals.

Since the White House is hell-bent on vaccinating the entire US population with a booster and a primary dose of the COVID-19 vaccination, the political force behind such an ambitious plan will direct the president and his advisers to dismiss the recommendations of the FDA committee at some point and in some format in the very near future.

Secondly, Biden is apparently pressuring India and Prime Minister Narendra Modi to resume vaccine exports to the global south, including to the wholly underserved countries in Africa and Central Asia. While a collective call from the outside looking in, the ebb and flow of this diplomatic discussion places America, again, in contradiction land. We reported recently that Modi suspended the exportation of AstraZeneca’s cheap-to-make COVID-19 vaccine earlier this year to deal with the spread of the novel coronavirus disease among India’s gargantuan population of 1.366 billion people.

A month ago, data indicated that at least two-thirds of the Indian population was exposed to the virus and that only a portion of the population, about 20% of the total adults in the country, have been jabbed with at least one dose of a COVID-19 vaccine. Of course, numbers are relative. But the optics of the US government pressuring another country that has the same, possibly greater, level of vaccine manufacturing capacity but a significantly larger population appears a bit selfish and dumbfounding.

By comparison, the total US population is over 54% fully vaccinated. Herd immunity is already in sight. Why can’t the U.S. spare some more vaccines and send them to the most vulnerable and neediest countries?

On a third note, the Biden administration emphasizes that they are already in the process of distributing vaccine doses to developing countries. But will it be enough? One of the biggest issues with the global vaccine drive has been the persistent failure of the COVAX consortium. The World Health Organization, a United Nations agency, announced early on in the pandemic the formation of the COVAX initiative consisting of national governments, non-governmental organizations, charities, and private companies working under one umbrella to coordinate and ensure the equitable distribution of vaccines across the world.

However, as the World Health Organization has declared for months, the majority of the vaccines administered throughout the world have been administered by only ten to fifteen of the largest and wealthiest countries. This, of course, includes the United States. Poorer countries, including India in the global south, are still struggling to implement vaccine drives at larger scales. Governments in countries such as South Sudan, Sudan, DR Congo, Zambia, Lesotho, and so many others, have been unable to deliver vaccines to their populations because, in part, the high concentration of doses already administered in highly developed countries in North America and Western Europe. That said, Biden’s attempt to play global citizen and friend to the developing world could fall short due to the chink in his armor: his domestic politics related to the COVID-19 vaccine.

It’s statecraft 101. In order to show force on the global stage, a national government must demonstrate that they have effectively or given the impression that they have balanced domestic politics. It’s cyclical. Domestic politics inform foreign policy. That said, how does Biden intend to show force through humanitarianism during his call for other governments to contribute to the efforts of countering global vaccine shortage when the discussion of vaccine policy isn’t even close to being settled on the United States domestic scene? Naturally, this is a rhetorical question. But a valid one that necessitates multiple answers from different perspectives on the subject matter.

Biden is setting himself up for an international embarrassment if he continues down this politically driven vaccine approach. We can sit and chat about mandatory vaccines for days and whether boosters are viable for the general public. But, for the case of addressing the problem globally, the issue of overcommitting resources to one policy and not enough to the other could have enumerable consequences, both politically, legally, and negatively with regards to the security of the domestic and international public health.

Quote from Wyttenbach

Your knowledge is outdated. See table: Table 2. COVID-19 cases by vaccination status between week 33 and week 36 2021.

Age class 40-80 more CoV-19 cases among vaccinated...And this is the only class of concern! If you add the 50..60% infection protected, then this signal is very alarming as it shows that now this group (the subgroup that had no infection so far) gets 3x more often CoV-19 than unvaccinated. This is the true sign of immune suppression!

This is from real PCR+ cases. Does not include the hidden ones. Has also nothing to do with missing vaccinated/unvaccinted!

OK - 3rd time of repeating. For you, and FM1 who incomprehensibly also seems unable to read my posts.

Those PHE figures use MIMS database which does not accurately determine total population. Because of the high vaccination in the higher age groups, small errors (2%) in total population (it is overestimated by MIMS because this counts all GP registrations and people often leave and never re-register) result in large errors in estimated unvaccinated population, hence changing the statistics. Using accurate measures (ONS census-based estimates) of population give the true figures.

I linked a BBC radio 4 more-or-less program talking about this (for FM1 who I feel unlike W is capable of understanding it).

Hope it can be listened to outside UK:

More or Less - Death, Tax and Dishwashers - BBC Sounds

Why is estimating the number of unvaccinated people so tricky? And how deadly is 2021?

www.bbc.co.uk

THH

Quote from JedRothwell

Here is a depressing article with social science stats describing people who refuse to be vaccinated.

https://fivethirtyeight.com/fe…ated-america-in-5-charts/

This chart is particularly depressing. This shows the harm caused by the antivaxxer Death Cult.

Display More

Yes, because people are imperfect, sites such as TrialSiteNews that propagate antivax stories uncritically, and have antivax-lite editorials which cast doubt on establishment analysis and push non-establishment crackpot theories always in one direction (don't trust the vaccines - pills are available that offer strong protection COVID) KILL PEOPLE.

This thread would have some danger of doing the same were these pernicious slanted and anti-science memes not put into context and refuted.

Quote from JedRothwell

For lenr-forum.com, this is business as usual. It is a little annoying that FM1 and others have no bullshit filter, and they will repost anything. On the other hand I suppose it is useful for the rest of us to know what the lunatic fringe is saying. I could find out from original sources but FM1 wades through this garbage so I don't have to.

I imagine you’ll enjoy this one then! It argues that “Liberals are telling you to take the vaccine in order to stop you from taking the vaccine, which is why you need to take the vaccine”

No, it’s not from The Onion…

Nolte: Howard Stern Proves Democrats Want Unvaccinated Trump Voters Dead

Do you want to know why I think Howard Stern is going full-monster with his mockery of three fellow human beings who died of the coronavirus? Because leftists…

www.breitbart.com

Pandemic of the Unvaccinated

“Preliminary data from several states over the last few months suggest that 99.5% of deaths from COVID-19 in the United States were in unvaccinated people…

The estimate is in line with findings from a June analysis from the Associated Press, which found that only 0.8% of people who died from COVID-19 in the US in May were vaccinated.”

99.5% of COVID-19 deaths in the US are now in unvaccinated people, CDC head says